PW Medtech Group Ltd. (1358) Stock Price & Analysis

1 Followers

1358 Stock Chart & Stats

HK$0.90HK$0.03(2.87%)

At close: Nov 06 4:00 PM GMT+8

Day’s Range: HKD 0.85 - HKD 0.90
52-Week Range: HKD 0.85 - HKD 1.46
Previous Close: HKD 0.87
Volume: N/A
Average Volume (3M): 482.83K
Market Cap: HKD 1.28B
Enterprise Value: HKD 506.82M
Total Cash (Recent Filing): HKD 1.83B
Total Debt (Recent Filing): HKD 21.03M
Price to Earnings (P/E): 26.7
Beta: 0.35
Next Earnings: Apr 01, 2027 (Est.)
EPS Estimate: N/A
Last Dividend Ex-Date: Nov 02, 2026
Dividend Yield: 3.46%

Bulls Say, Bears Say

Bulls Say

Very Low Leverage

The exceptionally low debt burden gives PW Medtech substantial financial flexibility and reduces exposure to interest costs or refinancing pressure. This conservative structure can help the company sustain operations, invest selectively, and absorb weaker trading conditions over the next several quarters.

Established Profitability

Despite the recent slowdown, the company continues to generate positive earnings and substantial operating profitability. This indicates that its medical-device activities retain economic value and provides an internal earnings base for ongoing investment, product support, and business continuity.

Historical Growth And Gross Margins

The multi-year record of growth and high gross margins suggests PW Medtech has developed commercially valuable products and healthcare relationships. If operating conditions stabilize, this prior performance provides a foundation for rebuilding revenue and preserving attractive economics.

Bears Say

Revenue And Margin Deceleration

The simultaneous contraction in revenue and profitability is a meaningful deterioration in operating momentum. Lower sales and weaker margins can reduce earnings power, limit reinvestment capacity, and make it harder for the company to sustain its earlier growth trajectory over coming quarters.

Weaker Cash Generation

Positive cash flow remains a support, but the decline in free cash flow and volatility across years weaken confidence in earnings conversion. Less consistent internally generated cash could constrain investment, shareholder distributions, or the company’s ability to respond flexibly to weaker demand.

Modest Returns On Equity

Low returns on the company’s substantial equity base indicate that capital is currently producing limited profitability despite the strong balance sheet. Unless returns improve, this may reduce the efficiency of retained capital and limit the long-term compounding benefit of the conservative structure.

PW Medtech Group Ltd. News

PW Medtech Subsidiary Moves to Delist from NEEQ with Minority Shareholder Protections

PW Medtech Group Ltd. ( ($HK:1358) ) just unveiled an announcement. PW Medtech has disclosed that the board of its 53.10%-owned subsidiary Sichuan Ruijian Medical Technology has proposed a voluntary

2w agoPWE 1358

PW Medtech Subsidiary Enters Bankruptcy as Creditors Approve Asset Auction Plan

The latest announcement is out from PW Medtech Group Ltd. ( ($HK:1358) ). PW Medtech Group has disclosed that its indirect wholly owned subsidiary Xuzhou Yijia Medical Device Co., Ltd.

1M agoPWE 1358

PW Medtech Earnings Slide Prompts Dividend Cut

PW Medtech Group Ltd. ( ($HK:1358) ) has shared an announcement. PW Medtech Group Ltd. reported interim revenue of RMB394.1 million for the six months ended June 30, 2026, down

2M agoPWE 1358

PW Medtech Declares Interim Dividend for First Half of 2026

An update from PW Medtech Group Ltd. ( ($HK:1358) ) is now available. PW Medtech Group Limited has declared an interim ordinary cash dividend of HKD 0.011 per share for

2M agoPWE 1358

PW Medtech Subsidiary Posts Higher Interim Profit Amid Rising Liabilities

The latest update is out from PW Medtech Group Ltd. ( ($HK:1358) ). PW Medtech’s subsidiary Sichuan Ruijian Medical reported modest but steady growth in its interim unaudited results for

2M agoPWE 1358

PW Medtech Sets August Board Meeting to Review Interim Results and Dividend

The latest update is out from PW Medtech Group Ltd. ( ($HK:1358) ). PW Medtech Group Ltd. has scheduled a board meeting for 28 August 2026 to review and approve

2M agoPWE 1358

PW Medtech warns of sharp profit drop on infusion set price cuts

PW Medtech Group Ltd. ( ($HK:1358) ) has issued an update. PW Medtech has warned that its net profit for the six months ended June 30, 2026 is expected to

3M agoPWE 1358

PW Medtech Wins Full Shareholder Backing at 2026 AGM, Secures Capital Mandates

PW Medtech Group Ltd. ( ($HK:1358) ) just unveiled an update. PW Medtech Group Ltd. secured shareholder approval for all resolutions tabled at its annual general meeting held on June

4M agoPWE 1358

PW Medtech Tightens Grip on Sichuan Ruijian Via Share Buyback Plan

PW Medtech Group Ltd. ( ($HK:1358) ) has provided an announcement. PW Medtech’s non-wholly owned subsidiary Sichuan Ruijian Medical has approved a share repurchase programme on China’s NEEQ market, authorising

6M agoPWE 1358

PW Medtech Sets 2026 AGM to Approve Dividend, Board Changes and Capital Mandates

PW Medtech Group Ltd. ( ($HK:1358) ) has provided an announcement. PW Medtech Group Limited has called its 2026 annual general meeting for June 26, 2026, in Beijing, where shareholders

6M agoPWE 1358

1358 FAQ

What was PW Medtech Group Ltd.’s price range in the past 12 months?

PW Medtech Group Ltd. lowest stock price was HK$0.85 and its highest was HK$1.46 in the past 12 months.

What is PW Medtech Group Ltd.’s market cap?

PW Medtech Group Ltd.’s market cap is HK$1.28B.

When is PW Medtech Group Ltd.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were PW Medtech Group Ltd.’s earnings last quarter?

PW Medtech Group Ltd. released its earnings results on Aug 28, 2026. The company reported HK$0.012 earnings per share for the quarter.

Is PW Medtech Group Ltd. overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does PW Medtech Group Ltd. pay dividends?

PW Medtech Group Ltd. pays a Semiannually dividend of HK$0.011 which represents an annual dividend yield of 3.46%. See more information on PW Medtech Group Ltd. dividends here

What is PW Medtech Group Ltd.’s EPS estimate?

PW Medtech Group Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does PW Medtech Group Ltd. have?

PW Medtech Group Ltd. has 1,433,241,100 shares outstanding.

What happened to PW Medtech Group Ltd.’s price movement after its last earnings report?

PW Medtech Group Ltd. reported an EPS of HK$0.012 in its last earnings report. Following the earnings report the stock price went up 1.126%.

Which hedge fund is a major shareholder of PW Medtech Group Ltd.?

Currently, no hedge funds are holding shares in HK:1358

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description